Hijacking the intrinsic vitamin B<sub>12</sub> pathway for the oral delivery of nanoparticles, resulting in enhanced <i>in vivo</i> anti-leishmanial activity-Reference-Cited by-同舟云学术

Hijacking the intrinsic vitamin B₁₂ pathway for the oral delivery of nanoparticles, resulting in enhanced in vivo anti-leishmanial activity

Published:2022 Issue:19 Volume:10 Page:5669-5688
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Singh Aakriti¹,Yadagiri Ganesh¹,Javaid Aaqib¹,Sharma Krishna Kumar²,Verma Anurag²,Singh Om Prakash³^ORCID,Sundar Shyam⁴,Mudavath Shyam Lal¹^ORCID

Affiliation:

1. Infectious Disease Biology Laboratory, Chemical Biology Unit, Institute of Nano Science and Technology, Knowledge City, Sector-81, Mohali, Punjab 140306, India

2. Department of Pharmacy, Teerthanker Mahaveer University, Moradabad, Uttar Pradesh 244001, India

3. Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, Uttar Pradesh 221005, India

4. Infectious Disease Research Laboratory, Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh 221005, India

Abstract

VBS-AmB-SLN as a stable oral anti-leishmanial carrier.

Funder

Institute of Nano Science and Technology

Department of Science and Technology, Ministry of Science and Technology, India

Science and Engineering Research Board

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2022/BM/D2BM00979J